Form 4 for CAPR CAPRICOR THERAPEUTICS, INC.
Accepted 2026-05-04 16:30:07 ET · period of report 2026-05-01 · accession 0001593087-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-05-04 16:30 | 2026-05-01 | CAPR | Bergmann Anthony | CFO | M - OptEx | $3.18 | +25.0K | 33.2K | +304% | +$79.5K |
| DT | 2026-05-04 16:30 | 2026-05-01 | CAPR | Bergmann Anthony | CFO | S - Sale+OE | $31.70 | -25.0K | 8,223 | -75% | -$792.5K |
| DT | 2026-05-04 16:30 | 2026-05-01 | CAPR | Bergmann Anthony | CFO | M - OptEx | $0.00 | -25.0K | 117.0K | -18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-01 | M | A | 25,000 | $3.18 | 33,223 | D | — | — | |
| 2 | Common | Common Stock | 2026-05-01 | S | D | 25,000 | $31.70 | 8,223 | D | — | — | (F1) Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. (F2) The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.89 to $33.19, inclusive. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-05-01 | M | D | 25,000 | $0.00 | 116,980 | D | $3.18 · — to 2032-01-03 | 25,000 Common Stock | (F3) Shares vested 1/48th on the first day of each month commencing February 1, 2022. |